Track topics on Twitter Track topics that are important to you
Celladon Corporation, based in La Jolla, California, was launched in October 2004 as a privately held biotechnology company founded with the goal of becoming the leader in developing molecular therapies for the treatment of heart failure. The companyâs products target the key enzyme deficiency in advanced heart failure, SERCA2a, which regulates calcium cycling and contractility in heart muscle cells. Celladonâs first product candidate, MYDICARÂ®, delivers the gene for the SERCA2a enzyme and is currently being tested in Phase 1 and 2 clinical trials. Celladon is also developing traditional small molecule activators of SERCA2a for the treatment of heart failure. To learn more about Celladon, visit Celladonâs website at www.celladon.net.
2223 Avenida de la Playa #206
United States of America
SAN DIEGO, March 09, 2016 (GLOBE NEWSWIRE) -- Celladon Corporation (Nasdaq:CLDN) announced today that Institutional Shareholder Services ("ISS") and Glass Lewis & Co., two of the leading inde...
Eiger Biopharmaceuticals has merged with what is left of gene therapy developer Celladon in a deal that will see the combined firm list on the NASDAQ.
SAN DIEGO, March 21, 2016 (GLOBE NEWSWIRE) -- Celladon Corporation (Nasdaq:CLDN) announced today that, based upon the final vote count certified by the independent inspector of elections for the ...
SAN DIEGO, Feb. 10, 2016 (GLOBE NEWSWIRE) -- Celladon Corporation (Nasdaq:CLDN) announced today it has set a date for a special meeting of its stockholders to vote on matters related to the propo...
DIE FOLGENDEN AKTIEN SIND AB SOFORT AUSGESETZT: THE FOLLOWING SHARES ARE SUSPENDED WITH IMMEDIATE EFFECT: INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTIL CELLADON CORP. 72C US15117E1073 BAW/UFN LO...
Company INTERNATIONAL BUSINESS MACHINES CORPORATION TIDM IBM Headline Notification of filing of document The Corporation's current report on Form 8-K dated [January 26, 2016] was filed with the Un...
CompanyINTERNATIONAL BUSINESS MACHINES CORPORATION TIDMIBM HeadlineNotification of filing of document The Corporation's current report on Form 8-K dated February 25, 2016 was filed with the United...
ORION CORPORATION STOCK EXCHANGE RELEASE 14 June 2016 at 18.30 EEST Orion Corporation: Acquisition of own shares 14 June 2016 SHARE REPURCHASE 14 June 2016 Nasdaq Helsink...
Celladon Corp., based in La Jolla, Calif., was launched in October 2004 as a privately held biotechnology company with the goal of becoming the leader in developing molecular therapies for the treatme...
Celladon Corporation, based in La Jolla, California, was launched in October 2004 as a privately held biotechnology company founded with the goal of becoming the leader in develop...
We have published hundreds of Celladon Corporation news stories on BioPortfolio along with dozens of Celladon Corporation Clinical Trials and PubMed Articles about Celladon Corporation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Celladon Corporation Companies in our database. You can also find out about relevant Celladon Corporation Drugs and Medications on this site too.
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...
Enzymes are proteins that catalyze (i.e., increase the rates of) chemical reactions. In enzymatic reactions, the molecules at the beginning of the process, called substrates, are converted into different molecules, called products. Almost all chemical re...